This study is the first to systematically explore the role of Jag2 in hypoxic PAH, revealing that Jag2 promotes vascular inflammation and remodeling via activation of the NOX2/ROS pathway. This evidence concerns the gene JAG2 and pulmonary arterial hypertension.